Category: Prescription Drugs
Prescription Drugs market research reports by DelveInsight
-
OLUMIANT Market Drug Insight and Market Forecast − 2032
OLUMIANT Market Drug Insight and Market Forecast − 2032 “OLUMIANT Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about OLUMIANT for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the OLUMIANT for atopic dermatitis in the 7MM, i.e., Un ... Read More
-
VX15 (pepinemab) Emerging Drug Insight and Market Forecast – 2032
VX15 (pepinemab) Emerging Drug Insight and Market Forecast – 2032 “VX15 (pepinemab) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VX15 (pepinemab) for Huntington’s disease in the 7MM. A detailed picture of the VX15 (pepinemab) for Huntington’s disease ... Read More
-
VVZ-149 Emerging Drug Insight and Market Forecast – 2032
VVZ-149 Emerging Drug Insight and Market Forecast – 2032 “VVZ-149 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VVZ-149 for Postoperative Pain in the United States. A detailed picture of the VVZ-149 for Postoperative Pain in the United States for the ... Read More
-
WAYLIVRA Market Drug Insight and Market Forecast − 2032
WAYLIVRA Market Drug Insight and Market Forecast − 2032 “WAYLIVRA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about WAYLIVRA for Severe Hypertriglyceridemia (SHTG) in the five major markets. A detailed picture of the WAYLIVRA for severe hypertriglyceridemia ... Read More
-
TREMFYA Emerging Drug Insight and Market Forecast − 2032
TREMFYA Emerging Drug Insight and Market Forecast − 2032 “TREMFYA Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TREMFYA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the TREMFYA for ulcerative colitis in the 7MM, i.e., ... Read More
-
Opdivo (nivolumab) + Yervoy (ipilimumab) Drug Insight and Market Forecast – 2032
Opdivo (nivolumab) + Yervoy (ipilimumab) Drug Insight and Market Forecast – 2032 “Opdivo (nivolumab) + Yervoy (ipilimumab) Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Opdivo (nivolumab) + Yervoy (ipilimumab) for Metastatic Colorectal Cancer in the 7MM. A det ... Read More
-
ARQ-151 Emerging Drug Insight and Market Forecast − 2032
ARQ-151 Emerging Drug Insight and Market Forecast − 2032 “ARQ-151 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ARQ-151 for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the ARQ-151 for atopic dermatitis in the 7MM, i.e., Un ... Read More
-
UX701 Emerging Drug Insight and Market Forecast – 2032
UX701 Emerging Drug Insight and Market Forecast – 2032 “UX701 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about UX701 for Wilson’s disease in the 7MM. A detailed picture of the UX701 for Wilson’s disease in the 7MM, i.e., United States, EU4 (Germany, Fran ... Read More
-
AUSTEDO Drug Insight and Market Forecast – 2032
AUSTEDO Drug Insight and Market Forecast – 2032 “AUSTEDO Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AUSTEDO for Huntington’s disease in the United States. A detailed picture of the AUSTEDO for Huntington’s disease in the United States for the study period 2 ... Read More
-
LY3484356 (Imlunestrant) Emerging Drug Insight and Market Forecast – 2032
LY3484356 (Imlunestrant) Emerging Drug Insight and Market Forecast – 2032 “LY3484356 (Imlunestrant) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LY3484356 (Imlunestrant) for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the ... Read More
-
HUMIRA Drug Insight and Market Forecast – 2032
HUMIRA Drug Insight and Market Forecast – 2032 “HUMIRA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about HUMIRA for Rheumatoid Arthritis in the 7MM. A detailed picture of the HUMIRA for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France, It ... Read More
-
SHR0302 Emerging Drug Insight and Market Forecast − 2032
SHR0302 Emerging Drug Insight and Market Forecast − 2032 “SHR0302 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SHR0302 for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the SHR0302 for ulcerative colitis in the 7MM, i.e., ... Read More
-
XELJANZ Drug Insight and Market Forecast – 2032
XELJANZ Drug Insight and Market Forecast – 2032 “XELJANZ Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XELJANZ for Rheumatoid Arthritis in the 7MM. A detailed picture of the XELJANZ for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France ... Read More
-
BT-11 Emerging Drug Insight and Market Forecast − 2032
BT-11 Emerging Drug Insight and Market Forecast − 2032 “BT-11 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about BT-11 for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the BT-11 for ulcerative colitis in the 7MM, i.e., the Unit ... Read More
-
CAEL-101 Emerging Drug Insight and Market Forecast – 2032
CAEL-101 Emerging Drug Insight and Market Forecast – 2032 “CAEL-101 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CAEL-101 for AL Amyloidosis in the 7MM. A detailed picture of the CAEL-101 for AL Amyloidosis in the 7MM, i.e., United States, EU5 (Germa ... Read More
-
Difelikefalin Emerging Drug Insight and Market Forecast − 2032
Difelikefalin Emerging Drug Insight and Market Forecast − 2032 “Difelikefalin Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about difelikefalin for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the difelikefalin for atopic dermati ... Read More
-
Tukysa (tucatinib) ± Herceptin (trastuzumab) Emerging Drug Insight and Market Forecast – 2032
Tukysa (tucatinib) ± Herceptin (trastuzumab) Emerging Drug Insight and Market Forecast – 2032 “Tukysa (tucatinib) ± Herceptin (trastuzumab) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Tucatinib ± Trastuzumab for Metastatic Colorectal Cancer (mCRC) i ... Read More
-
Eftilagimod alpha (IMP321) Emerging Drug Insight and Market Forecast – 2035
Eftilagimod alpha (IMP321) Emerging Drug Insight and Market Forecast – 2035 “Eftilagimod alpha (IMP321) Emerging Drug Insight and Market Forecast – 2035” report provides comprehensive insights about Eftilagimod alpha (IMP321) for LAG-3 Next-generation Immunotherapies in the 7MM. A detailed picture o ... Read More
-
AMT-130 Emerging Drug Insight and Market Forecast – 2032
AMT-130 Emerging Drug Insight and Market Forecast – 2032 “AMT-130 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AMT-130 for Huntington’s disease in the 7MM. A detailed picture of the AMT-130 for Huntington’s disease in the 7MM, i.e., the United States ... Read More
-
REMICADE Drug Insight and Market Forecast – 2032
REMICADE Drug Insight and Market Forecast – 2032 “REMICADE Drug Insight and Market Forecast – 2032” report provides comprehensive insights about REMICADE for Rheumatoid Arthritis in the 7MM. A detailed picture of the REMICADE for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, Fr ... Read More
-
VTX-801 Emerging Drug Insight and Market Forecast – 2032
VTX-801 Emerging Drug Insight and Market Forecast – 2032 “VTX-801 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VTX-801 for Wilson’s disease in the 7MM. A detailed picture of the VTX-801 for Wilson’s disease in the 7MM, i.e., United States, EU4 (Germa ... Read More
-
SIMPONI Market Drug Insight and Market Forecast − 2032
SIMPONI Market Drug Insight and Market Forecast − 2032 “SIMPONI Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SIMPONI for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the SIMPONI for ulcerative colitis in the 7MM, i.e., the ... Read More
-
ACTEMRA Drug Insight and Market Forecast – 2032
ACTEMRA Drug Insight and Market Forecast – 2032 “ACTEMRA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ACTEMRA for Rheumatoid Arthritis in the 7MM. A detailed picture of the ACTEMRA for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France ... Read More
-
SMYRAF Drug Insight and Market Forecast – 2032
SMYRAF Drug Insight and Market Forecast – 2032 “SMYRAF Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SMYRAF for Rheumatoid Arthritis in Japan. A detailed picture of the SMYRAF for Rheumatoid Arthritis in Japan for the study period 2019–2032 is provided in this ... Read More
-
JYSELECA Drug Insight and Market Forecast – 2032
JYSELECA Drug Insight and Market Forecast – 2032 “JYSELECA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about JYSELECA for Rheumatoid Arthritis in the 6MM. A detailed picture of the JYSELECA for Rheumatoid Arthritis in the 6MM, i.e., EU4 (Germany, France, Italy, Sp ... Read More
Research Assistance
